|
METT11D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.08249994815679E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.05070000267338E-08 |
| Normal-vs-Stage2 |
3.641600E-03 |
| Normal-vs-Stage3 |
7.70350000456332E-08 |
| Normal-vs-Stage4 |
3.52439999995457E-06 |
| Stage1-vs-Stage2 |
2.759400E-01 |
| Stage1-vs-Stage3 |
3.309800E-01 |
| Stage1-vs-Stage4 |
2.390000E-01 |
| Stage2-vs-Stage3 |
1.450590E-01 |
| Stage2-vs-Stage4 |
1.343960E-01 |
| Stage3-vs-Stage4 |
7.833200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1709999969689E-08 |
| Normal-vs-AfricanAmerican |
2.41599999994957E-06 |
| Normal-vs-Asian |
3.903400E-03 |
| Caucasian-vs-AfricanAmerican |
3.018800E-01 |
| Caucasian-vs-Asian |
8.932100E-02 |
| AfricanAmerican-vs-Asian |
3.301700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58898999998991E-05 |
| Normal-vs-Female |
1.44370000398908E-08 |
| Male-vs-Female |
1.614640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.36200000167008E-08 |
| Normal-vs-Age(41-60Yrs) |
9.22789999968643E-08 |
| Normal-vs-Age(61-80Yrs) |
1.57284999999785E-05 |
| Normal-vs-Age(81-100Yrs) |
3.260400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.755800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.650800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.083400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.443600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.236400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.819400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.977200E-04 |
| Classical-VS-Follicular |
6.616400E-01 |
| Classical-VS-Other |
8.541400E-01 |
| Classical-VS-Normal |
4.30179999955094E-07 |
| Tall-VS-Follicular |
1.424610E-03 |
| Tall-VS-Other |
1.247390E-01 |
| Tall-VS-Normal |
3.39330008536365E-10 |
| Follicular-VS-Other |
7.726600E-01 |
| Follicular-VS-Normal |
1.788290E-04 |
| Other-VS-Normal |
1.885780E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79779999998075E-07 |
| Normal-vs-N1 |
4.427300E-04 |
| N0-vs-N1 |
8.833000E-01 |
|
|
